Showing results (591-600 of 921) with videos related to

Sort By:
Pageof 93
Substance Use & Misuse|February 19, 2025
Exploring the Role of Reward Functioning in the Overlap of Post-Traumatic Stress and Cocaine Use DisorderKate Hull, Hanaan Bing-Canar, Krista Miloslavich, et al.
Contemporary Clinical Trials|December 31, 2017
A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individualJoy M Schmitz, Angela L Stotts, Anka A Vujanovic, et al.
Behavioural Brain Research|July 13, 2015
Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjectsNadeeka R Dias, Joy M Schmitz, Nuvan Rathnayaka, et al.
Circulation|August 1, 1985
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptorsP Apprill, J M Schmitz, W B Campbell, et al.
Anticancer Research|September 2, 1999
A novel human malignant fibrous histiocytoma cell line of the heart (MFH-H) with secretion of hematopoietic growth factorsP Reinecke, R Moll, B Hildebrandt, et al.
Drug and Alcohol Dependence|August 15, 2000
Cocaine dependence with and without comorbid depression: a comparison of patient characteristicsJ M Schmitz, A L Stotts, P M Averill, et al.
Scientific Reports|September 25, 2023
Genomic characterization of rare earth binding by Shewanella oneidensisSean Medin, Alexa M Schmitz, Brooke Pian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Epidemiological study of p53 tumor suppressor gene mutations in patients from Luxembourg and the German Saar region with an advanced colorectal cancer using PCR-SSCP analysisM Pauly, M Schmitz, I Kayser, et al.
Journal of CME|July 23, 2025
Does Education Design Matter? Evaluating an Evidence-Based Continuing Education Intervention on Genomic Testing for Primary Care; a Pre-Test Post-Test StudySharon Mitchell, Felix M Schmitz, Janusz Janczukowicz, et al.
Lancet (London, England)|January 24, 2004
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trialR van Koningsveld, P I M Schmitz, F G Avander Meché, et al.
Pageof 93